Show simple item record

Authordc.contributor.authorPrieto Domínguez, Juan Carlos
Authordc.contributor.authorRossel Mariángel, Víctor
Authordc.contributor.authorLarrea, Ricardo
Authordc.contributor.authorBarría Pérez, Alberto Eduardo
Authordc.contributor.authorVenegas, Juan Carlos
Authordc.contributor.authorVerdugo, Fernando
Authordc.contributor.authorPotthoff, Marcelo
Authordc.contributor.authorGidi, Carlos
Authordc.contributor.authorVillablanca, Alex
Authordc.contributor.authorCriollo, Iván
Authordc.contributor.authorNoriega, Viviana
Authordc.contributor.authorCumsille, Francisco
Authordc.contributor.authorLlancaqueo Valeri, Marcelo Claudio
Authordc.contributor.authorLanas, Fernando
Admission datedc.date.accessioned2022-11-24T14:21:53Z
Available datedc.date.available2022-11-24T14:21:53Z
Publication datedc.date.issued2022
Cita de ítemdc.identifier.citationRev Med Chile 2022; 150: 711-719es_ES
Identifierdc.identifier.issn0717-6163
Identifierdc.identifier.issn0034-9887
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/189352
Abstractdc.description.abstractBackground: Patients with a cardiovascular (CV) history may be at greater risk of becoming ill and die due to SARS-CoV-2. Aim: To assess the incidence of CV complications in COVID-19 patients, the type of complication, and their association with CV history. Material and Methods: The clinical course of 1,314 patients with COVID-19 admitted consecutively to critical care units of 10 Chilean hospitals was registered between April and August of 2020. Results: The median age of patients was 59 years and 66% were men. One hundred-four (8%) had a CV history, namely heart failure (HF) in 53 (4.1%), coronary heart disease in 50 (3.8 %), and atrial fibrillation in 36 (2.7 %). There were CV complications in 359 patients (27.3%). The most common were venous thrombosis in 10.7% and arrhythmias in 10.5%, HF in 7.2%, type 2 acute myocardial infarction in 4.2%, arterial thrombosis in 2.0% and acute coronary syndrome (ACS) in 1.6%. When adjusted by age, sex and risk factors, only HF (Odds ratio (OR) = 7.16; 95% confidence intervals (CI), 3.96-12.92) and ACS (OR = 5.44; 95% CI, 1.50-19.82) were significantly associated with CV history. There was no association with arrhythmias, type 2 acute myocardial infarction, arterial or venous thrombosis. Conclusions: Patients with a history of CV disease are at greater risk of suffering HF and ACS when hospitalized due to COVID-19. Arrhythmias, type 2 AMI, and arterial or venous thrombosis occur with the same frequency in patients with or without CV history, suggesting that these complications depend on inflammatory phenomena related to the infection.es_ES
Patrocinadordc.description.sponsorshipSociedad Chilena de Cardiología y Cirugía Cardiovasculares_ES
Lenguagedc.language.isoeses_ES
Publisherdc.publisherSociedad Médica de Santiagoes_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
Sourcedc.sourceRevista Médica de Chilees_ES
Keywordsdc.subjectAcute Coronary Syndromees_ES
Keywordsdc.subjectCOVID-19 (Enfermedad)es_ES
Keywordsdc.subjectHeart diseaseses_ES
Keywordsdc.subjectIntensive Care Unitses_ES
Keywordsdc.subjectThrombosises_ES
Títulodc.titleComplicaciones cardiovasculares en pacientes COVID-19 hospitalizados en Unidades de Pacientes Críticos en Chile. Registro COVICARes_ES
Title in another languagedc.title.alternativeCardiovascular complications in COVID-19 patients admitted to intensive care units in Chilean hospitalses_ES
Document typedc.typeArtículo de revistaes_ES
dc.description.versiondc.description.versionVersión publicada - versión final del editores_ES
dcterms.accessRightsdcterms.accessRightsAcceso abiertoes_ES
Catalogueruchile.catalogadorlajes_ES
Indexationuchile.indexArtículo de publícación WoSes_ES
Indexationuchile.indexArtículo de publicación SciELOes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States